B. Roshan

发表

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

A. Krolewski, J. Warram, E. Rosolowsky, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney

L. Weinrauch, J. D'Elia, B. Roshan, 2009, International journal of nephrology and renovascular disease.

Diabetes and Nephropathy

B. Roshan, R. Solomon, 2001 .

Does Therapy Targeting Normal SBP of Less than 120 mm Hg Reduce Major CV Events in T2DM Patients?

B. Roshan, 2011, Current diabetes reports.

Activated ERK2 Interacts with and Phosphorylates the Docking Protein GAB1*

L. Cantley, K. Spokes, B. Roshan, 1999, The Journal of Biological Chemistry.

Non-Proteinuric Diabetic Nephropathy

V. Chawla, B. Roshan, 2014, Current Diabetes Reports.

Strive for kidney health for everyone during COVID-19; the possible theme for the world kidney day 2021

B. Lakkakula, B. Roshan, E. Mazaheri, 2020, Journal of Nephropharmacology.

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

J. Skupień, A. Krolewski, J. Warram, 2011, Journal of the American Society of Nephrology : JASN.

In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

A. Krolewski, J. Warram, B. Perkins, 2010, Kidney international.

Diabetes and Nephropathy

B. Roshan, R. Solomon, 2001 .

Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes

J. Weinberg, A. Krolewski, J. Warram, 2009, Diabetes Care.

Glomerulonephritis associated with SARS-CoV-2 infection

B. Lakkakula, B. Roshan, Banafsheh Yalameha, 2020, Journal of Nephropharmacology.

Improved glycemic control and platelet function abnormalities in diabetic patients with microvascular disease.

R. Gleason, G. Tofler, L. Weinrauch, 2000, Metabolism: clinical and experimental.

Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.

E. Schaefer, R. Desilva, O. Ganda, 2011, Journal of clinical lipidology.

Fibrinogen and factor VII levels improve with glycemic control in patients with type 1 diabetes mellitus who have microvascular complications.

R. Gleason, G. Tofler, L. Weinrauch, 2001, Archives of internal medicine.

The impact of a prior history of cardiovascular events on outcomes in patients on renal replacement therapy.

R. Gleason, L. Weinrauch, B. Roshan, 2012, International journal of cardiology.

A story of microalbuminuria and diabetic nephropathy.

B. Roshan, R. Stanton, 2013, Journal of nephropathology.

ERK Regulates the Hepatocyte Growth Factor-mediated Interaction of Gab1 and the Phosphatidylinositol 3-Kinase*

L. Cantley, B. Roshan, Cheng Fang Yu, 2001, The Journal of Biological Chemistry.

Aliskiren in the treatment of renal disease; a narrative review

B. Roshan, Tella Sadighpour, 2022, Journal of Parathyroid Disease.

Systemic lupus erythematosus following SARS-CoV-2 vaccination; a review of literature

Oscar Montes, B. Roshan, H. Jahantigh, 2022, Journal of Nephropharmacology.

Perspectives on the relationship of renal disease and coronavirus disease 2019

B. Roshan, Banafsheh Yalameha, Leila Mohmoodnia, 2020, Journal of Nephropharmacology.

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

A. Krolewski, W. Walker, J. Warram, 2009, American Society of Nephrology. Clinical Journal.

Diabetic microvascular complications: possible targets for improved macrovascular outcomes

R. Gleason, L. Weinrauch, J. D'Elia, 2010, International journal of nephrology and renovascular disease.

Diabetic Microvascular Complications: Possible Targets for Improved Macrovascular Outcomes International Journal of Nephrology and Renovascular Disease Dovepress

B. Roshan, Manish R. Maski, Citation D Elia, 2022 .

The impact of a prior history of cardiovascular events on outcomes in patients on renal replacement therapy.

R. Gleason, L. Weinrauch, B. Roshan, 2012, International journal of cardiology.

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

J. Skupień, A. Krolewski, J. Warram, 2011, Journal of the American Society of Nephrology : JASN.

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

A. Krolewski, W. Walker, J. Warram, 2009, Clinical journal of the American Society of Nephrology : CJASN.

The Fuzzy Connection between SARS-CoV-2 Infection and Loss of Renal Function

B. Roshan, H. Nasri, L. Bhaskar, 2020, American Journal of Nephrology.

International Journal of Nephrology and Renovascular Disease Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Manifestation of Renal Disease in Obesity: Pathophysiology of Obesity-related Dysfunction of the Kidney

L. Weinrauch, B. Roshan, Manish R. Maski, 2022 .